Skip navigation
Agenda

Explore the Impact of Copay Accumulators, Maximizers and Drug Pricing Legislation on Patient Affordability

October 2-4, 2019
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, OCTOBER 2, 2019

COPAY ACCUMULATORS
AND PATIENT ACCESS

7:30

Conference Registration & Continental Breakfast

8:30

Chairman’s Opening Remarks

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Understand the State of Copay Accumulator and
Maximizer Programs and Consider the Impact on
Patient Access, Adherence and Out-of-Pocket Costs

8:45

PANEL Multi-Stakeholder Perspectives on Addressing Patient Affordability for High-Cost Medications

MODERATOR:

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

PANELISTS:

Jim Clement
Partner,  Coeus Consulting Group;
former Executive Director, Value-Based Care and Supply Chain Strategy,
Aetna

Colette Flack
Sr. Director, Access and Patient Services
Dermira, Inc.

Amy Niles
Vice President, External Relations
Patient Access Network (PAN) Foundation

Stephen Carroll
Pharmacist
AllCare Specialty Pharmacy

9:45

PANELAnalyze State and Federal Progress Regulating Copay Accumulator Programs and Patient Advocacy Response

MODERATOR:

Alan Klein
Chief Development Officer
HealthWell Foundation

PANELISTS:

Anna Hyde
Vice President, Advocacy and Access
The Arthritis Foundation

Carl Schmid
Deputy Executive Director
The AIDS Institute

John A. Wylam, Esq.
Staff Attorney
Aimed Alliance

11:00

Networking and Refreshment Break

Evolving Copay Support to Address Market
Changes and Patient Needs

11:30

Explore Alternative Copay Strategies to Respond to the Rise of Copay Accumulator and Maximizer Programs

Bob Raffo
President & CEO
FirstView

12:30

Networking Luncheon

1:45

Measuring the Impact of Accumulator Programs

Speaker TBA

2:30

Consider the Expanded Role of Patient Assistance Programs

Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx

3:15

Networking and Refreshment Break

3:45

Examine Copay Network Data’s Potential Impact on Patient Access

Mark Hall
Chief Strategy Officer
G8way Health

4:30

Understand the Importance of Employers’ Shifts in Benefit Plan Design to
Address the Growing Costs of Advanced Therapeutics

Randy Vogenberg, PhD
Principal, Institute for Integrated Healthcare (IIH);
Board Chair,
Employer Provider Interface Council (EPIC) of the HQF (Hospital Quality Foundation)

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, OCTOBER 3, 2019

DRUG PRICING, TRANSPARENCY AND
COPAY DESIGN

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

8:45

Not Just a Copay Anymore —
Trends, Reform and Service Innovation in an Evolving Ecosystem

Ian Tzeng
Managing Director
L.E.K. Consulting

9:30

Adapting Copay Program Design to Address Access and Affordability Challenges

John Herley
Vice President, Business Development
ConnectiveRx

10:15

Networking and Refreshment Break

10:45

LEGAL UPDATE Assess the Status of Drug Pricing Legislation and Potential Impact on
Patient Access

Rujul H. Desai
Of Counsel
Covington & Burling LLP

11:30

Understand Coupon Impact on First Fill and Medication Abandonment Rates

Douglas Gabbard
President & CEO, Prescriptive Path;
former Director, Savings Offer Strategy, GSK

12:00

Networking Luncheon

1:15

Combatting Pharmacy Fraud Among Copay Programs

Paul LeVine
VP, Corporate Strategy
TrialCard

2:15

Where the Rubber Hits the Road —
A Health System’s Approach to Improving Specialty Patient Population Outcomes Through Coordination of Care and Patient Affordability

John Robicsek
Assistant Vice President, Strategy, Business and
Program Development, Pharmacy Administration
Atrium Health

Gale Wm. Fraser III
Operations Manager, Specialty Pharmacy Service
Atrium Health

3:00

Networking and Refreshment Break

3:30

ENFORCEMENT PANEL SESSION Examine Compliance Trends within Patient Assistance Programs

MODERATOR:

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

PANELISTS:

Eric Rubenstein
Fraud and Abuse Consultant, Advize Health LLC;
former Senior Special Agent, U.S. Department of Health and Human Services,
OIG

Bernard Cooney
Assistant United States Attorney
District of New Jersey

Charlene Fullmer
Deputy Chief for Affirmative Litigation, Civil Division, U.S. Attorney’s Office
District of Eastern Pennsylvania

4:30

PAP Compliance Trends and Implications for Copay Programs

Stefanie Doebler
Of Counsel
Covington & Burling LLP

Liza Khan
Associate
Covington & Burling LLP

5:15

Assess the Real Impact of Prescription Drug Copay Assistance Programs on Overall Healthcare Costs

Robert J. Leinss, Jr., BS Pharm, RPh, MBA
Specialty Pharmacy Consulting Services

6:00

Close of Day Two

Networking, Wine and Cheese Reception immediately following the final session on day two

DAY THREE FRIDAY, OCTOBER 4, 2019

COPAY PROGRAM INNOVATION AND EXECUTION

7:30

Continental Breakfast

8:00

Chairperson’s Review of Day One

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

8:15

Implement Performance Measurements to Justify the Cost of Copay Programs

Brent Schwartz
Executive Director, Marketing and Access
Allergan

9:00

Affordability First — The Future of Copay Assistance

Bob Raffo
President & CEO
FirstView

10:15

TWO CONCURRENT BREAKOUT SESSIONS (A-B)

A Copay 101 — Develop a Functional Business Model

Gerard Rivera, PharmD
CEO
Pacific Pharmacy Group

Andy Buzbee
VP, Business Development
ConnectiveRx

 
B Design Effective Strategies to Adjust Copay Programs to Fit the Specialty Model

Ticia Cawley
VP, Client Solutions
ConnectiveRx

Colette Flack
Sr. Director, Access and Patient Services
Dermira, Inc.

11:30

Applying Wrap Around eServices to Retail Brands

Ticia Cawley
VP, Client Solutions
ConnectiveRx

12:15

Chairman’s Closing Remarks

12:30

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, OCTOBER 2, 2019

COPAY ACCUMULATORS
AND PATIENT ACCESS

7:30

Conference Registration & Continental Breakfast

8:30

Chairman’s Opening Remarks

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Understand the State of Copay Accumulator and
Maximizer Programs and Consider the Impact on
Patient Access, Adherence and Out-of-Pocket Costs

8:45

PANEL Multi-Stakeholder Perspectives on Addressing Patient Affordability for High-Cost Medications

MODERATOR:

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

PANELISTS:

Jim Clement
Partner,  Coeus Consulting Group;
former Executive Director, Value-Based Care and Supply Chain Strategy,
Aetna

Colette Flack
Sr. Director, Access and Patient Services
Dermira, Inc.

Amy Niles
Vice President, External Relations
Patient Access Network (PAN) Foundation

Stephen Carroll
Pharmacist
AllCare Specialty Pharmacy

9:45

PANELAnalyze State and Federal Progress Regulating Copay Accumulator Programs and Patient Advocacy Response

MODERATOR:

Alan Klein
Chief Development Officer
HealthWell Foundation

PANELISTS:

Anna Hyde
Vice President, Advocacy and Access
The Arthritis Foundation

Carl Schmid
Deputy Executive Director
The AIDS Institute

John A. Wylam, Esq.
Staff Attorney
Aimed Alliance

11:00

Networking and Refreshment Break

Evolving Copay Support to Address Market
Changes and Patient Needs

11:30

Explore Alternative Copay Strategies to Respond to the Rise of Copay Accumulator and Maximizer Programs

Bob Raffo
President & CEO
FirstView

12:30

Networking Luncheon

1:45

Measuring the Impact of Accumulator Programs

Speaker TBA

2:30

Consider the Expanded Role of Patient Assistance Programs

Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx

3:15

Networking and Refreshment Break

3:45

Examine Copay Network Data’s Potential Impact on Patient Access

Mark Hall
Chief Strategy Officer
G8way Health

4:30

Understand the Importance of Employers’ Shifts in Benefit Plan Design to
Address the Growing Costs of Advanced Therapeutics

Randy Vogenberg, PhD
Principal, Institute for Integrated Healthcare (IIH);
Board Chair,
Employer Provider Interface Council (EPIC) of the HQF (Hospital Quality Foundation)

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, OCTOBER 3, 2019

DRUG PRICING, TRANSPARENCY AND
COPAY DESIGN

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

8:45

Not Just a Copay Anymore —
Trends, Reform and Service Innovation in an Evolving Ecosystem

Ian Tzeng
Managing Director
L.E.K. Consulting

9:30

Adapting Copay Program Design to Address Access and Affordability Challenges

John Herley
Vice President, Business Development
ConnectiveRx

10:15

Networking and Refreshment Break

10:45

LEGAL UPDATE Assess the Status of Drug Pricing Legislation and Potential Impact on
Patient Access

Rujul H. Desai
Of Counsel
Covington & Burling LLP

11:30

Understand Coupon Impact on First Fill and Medication Abandonment Rates

Douglas Gabbard
President & CEO, Prescriptive Path;
former Director, Savings Offer Strategy, GSK

12:00

Networking Luncheon

1:15

Combatting Pharmacy Fraud Among Copay Programs

Paul LeVine
VP, Corporate Strategy
TrialCard

2:15

Where the Rubber Hits the Road —
A Health System’s Approach to Improving Specialty Patient Population Outcomes Through Coordination of Care and Patient Affordability

John Robicsek
Assistant Vice President, Strategy, Business and
Program Development, Pharmacy Administration
Atrium Health

Gale Wm. Fraser III
Operations Manager, Specialty Pharmacy Service
Atrium Health

3:00

Networking and Refreshment Break

3:30

ENFORCEMENT PANEL SESSION Examine Compliance Trends within Patient Assistance Programs

MODERATOR:

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

PANELISTS:

Eric Rubenstein
Fraud and Abuse Consultant, Advize Health LLC;
former Senior Special Agent, U.S. Department of Health and Human Services,
OIG

Bernard Cooney
Assistant United States Attorney
District of New Jersey

Charlene Fullmer
Deputy Chief for Affirmative Litigation, Civil Division, U.S. Attorney’s Office
District of Eastern Pennsylvania

4:30

PAP Compliance Trends and Implications for Copay Programs

Stefanie Doebler
Of Counsel
Covington & Burling LLP

Liza Khan
Associate
Covington & Burling LLP

5:15

Assess the Real Impact of Prescription Drug Copay Assistance Programs on Overall Healthcare Costs

Robert J. Leinss, Jr., BS Pharm, RPh, MBA
Specialty Pharmacy Consulting Services

6:00

Close of Day Two

Networking, Wine and Cheese Reception immediately following the final session on day two

DAY THREE FRIDAY, OCTOBER 4, 2019

COPAY PROGRAM INNOVATION AND EXECUTION

7:30

Continental Breakfast

8:00

Chairperson’s Review of Day One

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

8:15

Implement Performance Measurements to Justify the Cost of Copay Programs

Brent Schwartz
Executive Director, Marketing and Access
Allergan

9:00

Affordability First — The Future of Copay Assistance

Bob Raffo
President & CEO
FirstView

10:15

TWO CONCURRENT BREAKOUT SESSIONS (A-B)

A Copay 101 — Develop a Functional Business Model

Gerard Rivera, PharmD
CEO
Pacific Pharmacy Group

Andy Buzbee
VP, Business Development
ConnectiveRx

 
B Design Effective Strategies to Adjust Copay Programs to Fit the Specialty Model

Ticia Cawley
VP, Client Solutions
ConnectiveRx

Colette Flack
Sr. Director, Access and Patient Services
Dermira, Inc.

11:30

Applying Wrap Around eServices to Retail Brands

Ticia Cawley
VP, Client Solutions
ConnectiveRx

12:15

Chairman’s Closing Remarks

12:30

Close of Conference